BACKGROUND: It is unknown whether children born very preterm (< 32 weeks' gestation) with appropriate size for gestational age, who grow poorly in the first postnatal months (ie, preterm growth restraint), show a similar growth pattern as children born small for gestational age. OBJECTIVE: Childhood growth and adult height of children with preterm growth restraint were compared to those of very preterm small-for-gestational-age and non-preterm-growth-restraint children. METHODS: Data were drawn from the Project on Preterm and Small-for-Gestational-Age Infants cohort. Preterm growth restraint was considered to have occurred after appropriate-size-for-gestational-age birth and if length and/or weight was below -2 SD score at 3 months postterm. RESULTS: Among 380 very preterm children, 274 experienced no preterm growth restraint and showed near-normal growth, whereas 79 (21%) experienced preterm growth restraint and subsequently displayed a growth pattern similar to that of very preterm small-for-gestational-age children (n = 27). Adult height of these children was -1.1 to -1.2 SD score. Very preterm small-for-gestational-age and preterm-growth-restraint children with a height below -2 SD score at 5 years had an adult height of approximately -2.5 SD score. CONCLUSIONS: Childhood growth and adult height were similar in very preterm small-for-gestational-age and preterm-growth-restraint children. These long-term findings further strengthen the plausibility of extending the small-for-gestational-age indication for growth hormone therapy in such a way that preterm-growth-restraint children are no longer excluded if they have a short stature persisting beyond the age of approximately 5 years.
BACKGROUND: It is unknown whether children born very preterm (< 32 weeks' gestation) with appropriate size for gestational age, who grow poorly in the first postnatal months (ie, preterm growth restraint), show a similar growth pattern as children born small for gestational age. OBJECTIVE: Childhood growth and adult height of children with preterm growth restraint were compared to those of very preterm small-for-gestational-age and non-preterm-growth-restraint children. METHODS: Data were drawn from the Project on Preterm and Small-for-Gestational-Age Infants cohort. Preterm growth restraint was considered to have occurred after appropriate-size-for-gestational-age birth and if length and/or weight was below -2 SD score at 3 months postterm. RESULTS: Among 380 very preterm children, 274 experienced no preterm growth restraint and showed near-normal growth, whereas 79 (21%) experienced preterm growth restraint and subsequently displayed a growth pattern similar to that of very preterm small-for-gestational-age children (n = 27). Adult height of these children was -1.1 to -1.2 SD score. Very preterm small-for-gestational-age and preterm-growth-restraint children with a height below -2 SD score at 5 years had an adult height of approximately -2.5 SD score. CONCLUSIONS: Childhood growth and adult height were similar in very preterm small-for-gestational-age and preterm-growth-restraint children. These long-term findings further strengthen the plausibility of extending the small-for-gestational-age indication for growth hormone therapy in such a way that preterm-growth-restraint children are no longer excluded if they have a short stature persisting beyond the age of approximately 5 years.
Authors: V Pampanini; A Boiani; C De Marchis; C Giacomozzi; R Navas; R Agostino; F Dini; P Ghirri; S Cianfarani Journal: Eur J Pediatr Date: 2014-06-24 Impact factor: 3.183
Authors: Martijn J J Finken; Marlies Schrevel; Jeanine J Houwing-Duistermaat; Aan V Kharagjitsingh; Friedo W Dekker; Bobby P Koeleman; Bart O Roep; Jan M Wit Journal: J Bone Miner Metab Date: 2015-07-28 Impact factor: 2.626
Authors: Ayesha Sania; Christopher R Sudfeld; Goodarz Danaei; Günther Fink; Dana C McCoy; Zhaozhong Zhu; Mary C Smith Fawzi; Mehmet Akman; Shams E Arifeen; Aluisio J D Barros; David Bellinger; Maureen M Black; Alemtsehay Bogale; Joseph M Braun; Nynke van den Broek; Verena Carrara; Paulita Duazo; Christopher Duggan; Lia C H Fernald; Melissa Gladstone; Jena Hamadani; Alexis J Handal; Siobán Harlow; Melissa Hidrobo; Chris Kuzawa; Ingrid Kvestad; Lindsey Locks; Karim Manji; Honorati Masanja; Alicia Matijasevich; Christine McDonald; Rose McGready; Arjumand Rizvi; Darci Santos; Leticia Santos; Dilsad Save; Roger Shapiro; Barbara Stoecker; Tor A Strand; Sunita Taneja; Martha-Maria Tellez-Rojo; Fahmida Tofail; Aisha K Yousafzai; Majid Ezzati; Wafaie Fawzi Journal: BMJ Open Date: 2019-10-03 Impact factor: 2.692